A systematic review on the effect of bevacizumab in exudative age-related macular degeneration: a response to a letter to the editor by Schmucker et al.

被引：0
|
作者：
Schouten, Jan S. A. G. [1 ]
La Heij, Ellen C. [1 ]
Webers, Carroll A. B. [1 ]
Lundqvist, Igor J. [1 ]
Hendrikse, Fred [1 ]
机构：
[1] Maastricht Univ Hosp, Dept Ophthalmol, NL-6202 AZ Maastricht, Netherlands
来源：
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2010年 / 248卷 / 03期
关键词：
SAFETY;
D O I：
10.1007/s00417-009-1244-x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：453 / 454
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studies
    Baumal, Caroline R.
    Sorensen, Torben Lykke
    Karcher, Helene
    Freitas, Rita L.
    Becher, Anja
    Balez, Sebastien
    Clemens, Andreas
    Singer, Michael
    Kodjikian, Laurent
    ACTA OPHTHALMOLOGICA, 2023, 101 (02) : 123 - 139
  • [22] The Injection Practice Patterns of Retina Specialists in Managing Exudative Age-Related Macular Degeneration: A Retrospective Study
    Karimaghaei, Cina
    Ali, Amir
    Safdar, Nida
    Tanwani, Anika
    Schmitz-Brown, Mary
    Banaee, Touka
    El-Annan, Jaafar
    Gupta, Praveena K.
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 375 - 383
  • [23] Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration
    Sayanagi, K.
    Sharma, S.
    Kaiser, P. K.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (05) : 622 - 626
  • [24] Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration?
    Patel, Yogin
    Miller, Daniel M.
    Fung, Anne E.
    Hill, Lauren F.
    Rosenfeld, Philip J.
    OPHTHALMOLOGY RETINA, 2020, 4 (02): : 141 - 147
  • [25] Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration
    Dadgostar, Hajir
    Ventura, Alexandre A. C. M.
    Chung, Jeffrey Y.
    Sharma, Sumit
    Kaiser, Peter K.
    OPHTHALMOLOGY, 2009, 116 (09) : 1740 - 1747
  • [26] CLINICAL AND ELECTROPHYSIOLOGICAL EVALUATION AFTER INTRAVITREAL ZIV-AFLIBERCEPT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    de Oliveira Dias, Joao Rafael
    de Andrade, Gabriel Costa
    Kniggendorf, Vinicius Ferreira
    Novais, Eduardo Amorim
    Maia, Andre
    Meyer, Carsten
    Watanabe, Sung Eun Song
    Farah, Michel Eid
    Rodrigues, Eduardo Buschele
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (08): : 1499 - 1507
  • [27] Therapeutic Efficacy of Bevacizumab for Age-Related Macular Degeneration What are the Implications of CATT for Routine Management?
    Ziemssen, Focke
    Sobolewska, Bianka
    DRUGS & AGING, 2011, 28 (11) : 853 - 865
  • [28] Bevacizumab in age-related macular degeneration: why an off-label treatment is the preferred therapy?
    Kodjikian, Laurent
    EXPERT REVIEW OF OPHTHALMOLOGY, 2015, 10 (01) : 1 - 3
  • [29] Interventions for Age-Related Macular Degeneration Are Practice Guidelines Based on Systematic Reviews?
    Lindsley, Kristina
    Li, Tianjing
    Ssemanda, Elizabeth
    Virgili, Gianni
    Dickersin, Kay
    OPHTHALMOLOGY, 2016, 123 (04) : 884 - 897
  • [30] Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a Prospective Study
    Bashshur, Ziad F.
    Haddad, Zeina A.
    Schakal, Alexandre R.
    Jaafar, Rola F.
    Saad, Alain
    Noureddin, Baha' N.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 148 (01) : 59 - 65
12345